Codagenix, a company developing vaccines and viral therapies for illnesses ranging from the flu and respiratory viruses to dengue fever, has raised $20 million in a new round of financing. The company
Now a startup company named Celmatix is starting clinical trials for its technology, which aims to make the process more transparent and provide better therapies to women who want to get pregnant. The